Trump Expected to Announce Cannabis Rescheduling Imminently

Industry sources indicate President Trump plans to announce marijuana rescheduling as early as today, marking a potential watershed moment for the cannabis sector. The timing suggests Trump aims to deliver on campaign promises quickly, with rescheduling representing one of the most significant federal policy shifts the industry has awaited for decades.

Rescheduling marijuana from Schedule I to a lower classification would eliminate the punitive 280E tax provision that has crushed cannabis operator margins for years. Multi-state operators like Curaleaf (CURLF), Green Thumb Industries (GTBIF), and Trulieve (TCNNF) currently pay effective tax rates exceeding 70% due to their inability to deduct standard business expenses. Rescheduling would immediately boost cash flows and profitability across the sector.

The announcement would likely trigger massive trading volumes in cannabis stocks, which have languished near multi-year lows despite growing state-level legalization. The sector has shed over 80% of its value since 2021 peaks, with investors fleeing amid regulatory uncertainty and capital constraints. Major operators trade at fractions of traditional retail multiples, creating substantial upside potential if federal barriers fall.

Beyond immediate tax relief, rescheduling opens pathways for institutional investment, traditional banking services, and interstate commerce. Cannabis companies currently operate in regulatory silos, unable to move products across state lines or access conventional financing. Federal rescheduling removes these constraints, enabling true national market development and operational efficiencies.

The cannabis industry generates over $30 billion in annual sales across legal states, yet remains fragmented and capital-starved due to federal prohibition. Trump's swift action on rescheduling would validate his pro-business cannabis stance and potentially accelerate the timeline for comprehensive reform. Operators with strong balance sheets and multi-state footprints stand to benefit most from the regulatory shift, while smaller players may face increased competition as institutional capital floods the sector.